AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 15 filers reported holding AMBRX BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,979,730 | +48.4% | 606,933 | +112.4% | 0.00% | +100.0% |
| Q2 2023 | $4,702,885 | +1703843.8% | 285,716 | +822.0% | 0.00% | – |
| Q1 2023 | $276 | +541.9% | 30,989 | +64.9% | 0.00% | – |
| Q4 2022 | $43 | -100.0% | 18,793 | -83.5% | 0.00% | – |
| Q3 2022 | $123,000 | -54.8% | 113,692 | +10.6% | 0.00% | – |
| Q2 2022 | $272,000 | -36.7% | 102,776 | -1.6% | 0.00% | – |
| Q1 2022 | $430,000 | -51.6% | 104,429 | +6.1% | 0.00% | – |
| Q4 2021 | $889,000 | -53.4% | 98,419 | -30.4% | 0.00% | -100.0% |
| Q3 2021 | $1,909,000 | -32.4% | 141,431 | -1.8% | 0.00% | -50.0% |
| Q2 2021 | $2,824,000 | – | 144,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 11,304,573 | $100,836,791 | 27.58% |
| COMMODORE CAPITAL LP | 4,803,447 | $42,846,747 | 6.52% |
| VR Adviser, LLC | 3,298,577 | $29,423,307 | 5.74% |
| Cormorant Asset Management, LP | 8,500,000 | $75,820 | 4.99% |
| Ghost Tree Capital, LLC | 250,000 | $2,230,000 | 0.66% |
| TOMS Capital Investment Management LP | 1,000,000 | $8,920,000 | 0.55% |
| Artal Group S.A. | 702,291 | $6,264 | 0.37% |
| Fosun International Ltd | 249,190 | $2,222,775 | 0.21% |
| D. E. Shaw & Co., Inc. | 3,933,552 | $35,087,284 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 361,000 | $3,220,120 | 0.02% |